{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:33:24Z","timestamp":1780410804242,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2091,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.virol.2007.07.024","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T07:15:02Z","timestamp":1188458102000},"page":"206-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha"],"prefix":"10.1016","volume":"369","author":[{"given":"Josh Q.H.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Barab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay L.","family":"Schmaltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.virol.2007.07.024_bib1","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1128\/JVI.02075-06","article-title":"Capsid protein of Eastern equine encephalitis virus inhibits host cell gene expression","volume":"81","author":"Aguilar","year":"2007","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.07.024_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nbt0202-114","article-title":"Antibodies for defense against biological attack","volume":"20","author":"Casadevall","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.virol.2007.07.024_bib3","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1. Safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector","volume":"194","author":"Catanzaro","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2007.07.024_bib4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JVI.77.2.1621-1625.2003","article-title":"Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease","volume":"77","author":"Chinsangaram","year":"2003","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2007.07.024_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/exnr.1996.6398","article-title":"Recombinant adenovirus: a gene transfer vector for study and treatment of CNS diseases","volume":"144","author":"Davidson","year":"1997","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.virol.2007.07.024_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/taap.2002.9372","article-title":"Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles","volume":"180","author":"Demers","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7053","key":"10.1016\/j.virol.2007.07.024_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"issue":"5775","key":"10.1016\/j.virol.2007.07.024_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus\u2013host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virol.2007.07.024_bib9","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JVI.02073-06","article-title":"The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff","volume":"81","author":"Garmashova","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2007.07.024_bib10","first-page":"109","article-title":"Manipulation of adenovirus vectors","volume":"vol. 7","author":"Graham","year":"1991"},{"issue":"1","key":"10.1016\/j.virol.2007.07.024_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/viro.1999.9662","article-title":"Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection","volume":"257","author":"Grieder","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.virol.2007.07.024_bib12","first-page":"2265","article-title":"Alphaviruses","volume":"vol. 2","author":"Griffin","year":"2001"},{"issue":"806","key":"10.1016\/j.virol.2007.07.024_bib13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","article-title":"Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards","volume":"158","author":"Hanson","year":"1967","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virol.2007.07.024_bib14","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4 Suppl.","key":"10.1016\/j.virol.2007.07.024_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7205\/MILMED.170.4S.92","article-title":"History of U.S. military contributions to the study of viral encephalitis","volume":"170","author":"Hoke","year":"2005","journal-title":"Mil. Med."},{"issue":"1","key":"10.1016\/j.virol.2007.07.024_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymthe.2006.02.015","article-title":"Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication","volume":"14","author":"Huarte","year":"2006","journal-title":"Mol. Ther."},{"issue":"Pt 9","key":"10.1016\/j.virol.2007.07.024_bib17","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.81925-0","article-title":"A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus","volume":"87","author":"Hunt","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.07.024_bib18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.virol.2006.10.031","article-title":"Effect of exogenous interferon and an interferon inducer on Western equine encephalitis virus disease in a hamster model","volume":"360","author":"Julander","year":"2007","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2007.07.024_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.virol.2007.07.024_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00002030-200405210-00019","article-title":"Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector","volume":"18","author":"Kostense","year":"2004","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.virol.2007.07.024_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/027245701300060328","article-title":"Pharmacokinetics study of a novel chimeric single-chain variable fragment antibody against Western equine encephalitis virus","volume":"20","author":"Long","year":"2001","journal-title":"Hybridoma"},{"issue":"1\u20132","key":"10.1016\/j.virol.2007.07.024_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"11","key":"10.1016\/j.virol.2007.07.024_bib23","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1128\/JVI.74.11.5006-5015.2000","article-title":"Pegylated alpha interferon is an effective treatment for virulent Venezuelan equine encephalitis virus and has profound effects on the host immune response to infection","volume":"74","author":"Lukaszewski","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2007.07.024_bib24","series-title":"Virology Methods Manual","author":"Mahy","year":"1996"},{"issue":"13","key":"10.1016\/j.virol.2007.07.024_bib25","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.02775-06","article-title":"Enhanced antiviral activity against Foot-and-mouth disease virus by a combination of type I and II porcine interferons","volume":"81","author":"Moraes","year":"2007","journal-title":"J. Virol."},{"issue":"17\u201318","key":"10.1016\/j.virol.2007.07.024_bib26","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2005.01.032","article-title":"Efficacy of DNA vaccination against Western equine encephalitis virus infection","volume":"23","author":"Nagata","year":"2005","journal-title":"Vaccine"},{"issue":"Pt 8","key":"10.1016\/j.virol.2007.07.024_bib27","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1099\/vir.0.81815-0","article-title":"Infectivity variation and genetic diversity among strains of Western equine encephalitis virus","volume":"87","author":"Nagata","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"11\u201312","key":"10.1016\/j.virol.2007.07.024_bib28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24\u00a0h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Phillpotts","year":"2002","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virol.2007.07.024_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/444397","article-title":"Aerosol exposure to Western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques","volume":"192","author":"Reed","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"7090","key":"10.1016\/j.virol.2007.07.024_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon\u2013chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2007.07.024_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/viro.2002.1677","article-title":"Recombinant chimeric Western and Eastern equine encephalitis viruses as potential vaccine candidates","volume":"302","author":"Schoepp","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virol.2007.07.024_bib32","series-title":"Textbook of Military Medicine: Part I. Warfare, Weaponry, and the Casualty, Medical Aspects of Chemical and Biological Warfare","first-page":"561","article-title":"Viral encephalitides","author":"Smith","year":"1997"},{"issue":"11","key":"10.1016\/j.virol.2007.07.024_bib33","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2007.07.024_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4269\/ajtmh.2003.68.218","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated Western equine encephalitis virus vaccine candidates","volume":"68","author":"Turell","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"15","key":"10.1016\/j.virol.2007.07.024_bib35","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1128\/JVI.78.15.8219-8228.2004","article-title":"Characterization of the murine alpha interferon gene family","volume":"78","author":"van Pesch","year":"2004","journal-title":"J. Virol."},{"issue":"3\u20135","key":"10.1016\/j.virol.2007.07.024_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11068-005-8359-8","article-title":"Expression of coxsackie-adenovirus receptor (CAR) in the developing mouse olfactory system","volume":"34","author":"Venkatraman","year":"2005","journal-title":"J. Neurocytol."},{"issue":"15","key":"10.1016\/j.virol.2007.07.024_bib37","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J. Virol."},{"issue":"22","key":"10.1016\/j.virol.2007.07.024_bib38","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2007.03.042","article-title":"Complete protection of mice against a lethal dose challenge of Western equine encephalitis virus after immunization with an adenovirus-vectored vaccine","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virol.2007.07.024_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/viro.1998.9351","article-title":"Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD","volume":"250","author":"Zakhartchouk","year":"1998","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2007.07.024_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5","article-title":"Adenovirus-mediated gene transfer in olfactory neurons in vivo","volume":"30","author":"Zhao","year":"1996","journal-title":"J. Neurobiol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207004941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207004941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:50:38Z","timestamp":1758585038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682207004941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0042682207004941"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2007.07.024","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2007.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2007 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}